Abstract 12692: Overexpression of Myocardial Inducible Nitric Oxide Synthase Exacerbates Cardiac Dysfunction and Beta-Adrenergic Desensitization in Streptozotocin-Induced Diabetic Mice
Yixi Liu,Che Cheng,Xiaoqiang Sun,Jing Cao,Peng Zhou,David Herrington,Dalane Kitzman,David Zhao,Heng Jie Cheng
DOI: https://doi.org/10.1161/circ.142.suppl_3.12692
IF: 37.8
2020-11-17
Circulation
Abstract:Background: Recent evidence links impaired nitric oxide (NO) signaling pathway in the pathogenesis of diabetes-induced cardiac dysfunction. However, the different nitric oxide synthases (NOS) isoforms involved in this pathology are controversial. Recent reports have shown that in failing myocardium, increased inducible NOS (iNOS) contributes to the attenuation of β-adrenergic receptor (AR)-mediated inotropic effect. The alteration and functional significance of cardiac iNOS in diabetic cardiomyopathy (DCM) are unclear. We assessed the hypothesis that increased cardiomyocyte iNOS expression and stimulation may inhibit myocyte contraction, relaxation, [Ca 2+ ] i transient ([Ca 2+ ] iT ), and depress its response to β-AR stimulation, thereby directly contributing to the functional impairment in DCM. Methods: Left ventricular (LV) myocyte protein levels of 3 NOS and myocyte functional responses were evaluated in 2 groups of wild-type female mice (11/group): control and DCM-induced by streptozotocin (STZ) (at 10 weeks after receiving 200 mg/kg STZ, ip). In DCM, we further assessed myocyte contractile and ([Ca 2+ ] iT ) responses to β-AR stimulation by isoproterenol (ISO, 10 -8 M) with and without pretreatment of myocytes with a selective iNOS inhibitor, 1400W (10 -5 M). Results: Compared with controls, DCM myocytes had significantly increased iNOS (1.76 vs 1.03) with decreased eNOS (0.29 vs 0.34), but relatively unchanged nNOS (0.17 vs 0.18). These changes were followed by significantly reduced basal cell contraction (dL/dt max , 73.8 vs 140.7 μm/s), relaxation (dR/dt max , 61.5 vs 121.1 μm/s) and [Ca 2+ ] iT (0.17 vs 0.20). ISO-stimulated increases in dL/dt max (32% vs 59%), dR/dt max (30% vs 55%) and [Ca 2+ ] iT (17% vs 31%) were also significantly reduced. Moreover, in DCM myocytes, pretreatment with 1400W markedly improved myocyte basal contraction (128.0 μm/s) and relaxation (111.7 μm/s). The ISO-induced increases in dL/dt max (55%), dR/dt max (52%), and [Ca 2+ ] iT (29%) were also significantly augmented. Conclusions: Our findings indicate that myocardial iNOS is activated in diabetic mice and suggest that increased iNOS expression contributes to depressed myocardial contractility, impaired [Ca 2+ ] i regulation and β-adrenergic hyporesponsiveness.
cardiac & cardiovascular systems,peripheral vascular disease